Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2012 Jan 4;48(12):969–979. doi: 10.1007/s13312-011-0144-4

Case reports

Mi Jin Kim 1, Kee Taek Jang 2, Yon Ho Choe 1,✉, Prabhat S Malik 3, Shobha Broor 4, Sameer Bakhshi 3,✉, Mukul Aggarwal 6, K C Aggarwal 5,✉, Karamchand 6, Archana Aggarwal 7, Suneel C Mundkur 8,✉, Shrikiran Aroor 8, K Jayashree 8, P K Patra 9,✉, Uma S Nayak 9, T S Sushma 9, Ira Shah 10,11,✉, Aarti Rahangdale 10
PMCID: PMC7097704  PMID: 22253154

The content is available as a PDF (521.6 KB).

Contributor Information

Yon Ho Choe, Email: 101016@skku.edu.

Sameer Bakhshi, Email: sambakh@hotmail.com.

K. C. Aggarwal, Email: kcagg1955@rediffmail.com

Suneel C. Mundkur, Email: Suneel_cm@hotmail.com

P. K. Patra, Email: pratap_patra3@yahoo.co.in

Ira Shah, Email: irashah@pediatriconcall.com.

References

  • 1.Garey K.W., Streetman D.S., Rainish M.C. Azathioprine hypersensitivity reaction in a patient with ulcerative colitis. Ann Pharmacother. 1998;32:425–428. doi: 10.1345/aph.17395. [DOI] [PubMed] [Google Scholar]
  • 2.Paoluzi O.A., Crispino P., Amantea A., Pica R., Iacopini F., Consolazio A., et al. Diffuse febrile dermatosis in a patient with active ulcerative colitis under treatment with steroids and azathioprine: a case of Sweet’s syndrome. Case report and review of literature. Dig Liver Dis. 2004;36:361–366. doi: 10.1016/j.dld.2003.10.020. [DOI] [PubMed] [Google Scholar]
  • 3.El-Azhary R.A., Brunner K.L., Gibson L.E. Sweet syndrome as a manifestation of azathioprine hypersensitivity. Mayo Clin Proc. 2008;83:1026–1030. doi: 10.4065/83.9.1026. [DOI] [PubMed] [Google Scholar]
  • 4.Yiasemides E., Thom G. Azathioprine hypersensitivity presenting as a neutrophilic dermatosis in a man with ulcerative colitis. Australas J Dermatol. 2009;50:48–51. doi: 10.1111/j.1440-0960.2008.00503.x. [DOI] [PubMed] [Google Scholar]
  • 5.Su W.P., Liu H.N. Diagnostic criteria for Sweet’s syndrome. Cutis. 1986;37:167–174. [PubMed] [Google Scholar]
  • 6.Sarkany R.P., Burrows N.P., Grant J.W., Pye R.J., Norris P.G. The pustular eruption of ulcerative colitis: a variant of Sweet’s syndrome? Br J Dermatol. 1998;138:365–366. doi: 10.1046/j.1365-2133.1998.02099.x. [DOI] [PubMed] [Google Scholar]
  • 7.Kemmett D., Harrison D.J., Hunter J.A. Antibodies to neutrophil cytoplasmic antigens: serologic marker for Sweet’s syndrome. J Am Acad Dermatol. 1991;24:967–969. doi: 10.1016/0190-9622(91)70154-T. [DOI] [PubMed] [Google Scholar]
  • 8.El-Azhary R.A. Azathioprine: current status and future considerations. Int J Dermatol. 2003;42:335–341. doi: 10.1046/j.1365-4362.2003.01823.x. [DOI] [PubMed] [Google Scholar]
  • 9.Elston G.E., Johnston G.A., Mortimer N.J., Harman K.E. Acute generalized exanthematous pustulosis associated with azathioprine hypersensitivity. Clin Exp Dermatol. 2007;32:52–53. doi: 10.1111/j.1365-2230.2006.02257.x. [DOI] [PubMed] [Google Scholar]
  • 10.McGovern D.P., Travis S.P., Duley J., Shobowale-Bakreel M., Dalton H.R. Azathioprine intolerance in patients with IBD may be imidazole-related and is independent of TPMT activity. Gastroenterology. 2002;122:838–839. doi: 10.1053/gast.2002.32124. [DOI] [PubMed] [Google Scholar]

References

  • 1.Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic. Influenza, Bautista E., Chotpitayasunondh T., Gao Z., Harper S.A., Shaw M., et al. Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection. N Engl J Med. 2010;362:1708–1719. doi: 10.1056/NEJMra1000449. [DOI] [PubMed] [Google Scholar]
  • 2.Press Release from Press Information Bureau, Press Release. Government of India, May 26,2010, http://pib.nic.in/h1n1/h1n1.asp.
  • 3.Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) — United States, May–August 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1071–1074. [PubMed]
  • 4.Seiter K., Nadelman R.B., Liu D., Ahmad T., Montecalvo M.A. Novel influenza A (H1N1) in patients with hematologic malignancies. J Clin Oncol. 2010;28:e27–e29. doi: 10.1200/JCO.2009.25.8889. [DOI] [PubMed] [Google Scholar]
  • 5.Saurez J.G., Martin Y., Callejas M., Rodriguez-Dominguez M., Galán J.C., Burgaleta C., et al. Favourable outcome of pneumonia due to novel influenza A/H1N1 2009 virus in a splenectomised adult patient undergoing therapy for non Hodgkin lymphoma. Br J Haematol. 2010;148:805–814. doi: 10.1111/j.1365-2141.2009.07989.x. [DOI] [PubMed] [Google Scholar]
  • 6.Patel P., Sweiss K., Shatavi S., Peace D., Clark N., Rondelli D. The impact of novel influenza A (H1N1) after hematopoietic SCT. Bone Marrow Transplant. 2010;45:1756–1757. doi: 10.1038/bmt.2010.57. [DOI] [PubMed] [Google Scholar]
  • 7.Redelman-Sidi G., Sepkowitz K.A., Huang C.K., Park S., Stiles J., Eagan J., et al. H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect. 2009;60:257–263. doi: 10.1016/j.jinf.2010.01.009. [DOI] [PubMed] [Google Scholar]

References

  • 1.Ditullio M.V. Intramedullary spinal cord abscess: case report with review of 53 previously described cases. Surg Neurol. 1997;7:351–354. [PubMed] [Google Scholar]
  • 2.Menezes A.H., Graf C.J., Perret G.E. Spinal cord abscess: review. Surgical Neurology. 1977;8:461–467. [PubMed] [Google Scholar]
  • 3.Benzyl D., Epstein M.H., Knuckey N.W. Intramedullary epidermoid associated with an intramedullary spinal abscess secondary to a dermal sinus. Neurosurgery. 1992;30:118–121. doi: 10.1227/00006123-199201000-00022. [DOI] [PubMed] [Google Scholar]
  • 4.Murphy K.J., Brunberg J.A., Quit D.J., Kazanjian P.H. Spinal cord infection: myelitis and abscess formation. AJNR AM J Neuroradiol. 1998;19:341–348. [PMC free article] [PubMed] [Google Scholar]
  • 5.Hoda M.F., Prasad R., Singh V.P., Maurya P., Singh K., Sharma V. Spinal intramedullary tubercular abscess: a case report. Indian J Tuberc. 2005;52:211–214. [Google Scholar]
  • 6.Guzel N, Eras M, Guzel DK. A child with spinal intramedullary abscess. Childs Nerv Syst. 2003;19:773. doi: 10.1007/s00381-003-0802-5. [DOI] [PubMed] [Google Scholar]
  • 7.Schroeder K.A., Mckeever P.E., Schaberg D.R., Hoff J.T. Effect of dexamethasone on experimental brain abscess. J Neurosurgery. 1987;66:264–269. doi: 10.3171/jns.1987.66.2.0264. [DOI] [PubMed] [Google Scholar]
  • 8.Citow J.S., Ammirati M. Intramedullary tuberculoma of the spinal cord: Case report. Neurosurgery. 1994;35:327–330. doi: 10.1227/00006123-199408000-00024. [DOI] [PubMed] [Google Scholar]
  • 9.Kalia V., Vibhuti, Aggarwal T. Holocord intramedullary abscess: clinical brief. Indian J Pediatr. 2007;74:589–591. doi: 10.1007/s12098-007-0101-3. [DOI] [PubMed] [Google Scholar]

References

  • 1.Kliegman M.R., Behrman R.E., Jenson H.B., Stanton B.F., editors. Strongyloidiasis (Strongyloides Stercoralis). Nelson Textbook of Pediatrics. 18th Ed. Philadelphia (Pennsylvania): Saunders; 2008. pp. 1501–1502. [Google Scholar]
  • 2.Daubenton J.D., Buys H.A., Hartley P.S. Disseminated strongyloidiasis in a child with lymphoblastic lymphoma. J Pediatr Hematol Oncol. 1998;20:260–263. doi: 10.1097/00043426-199805000-00014. [DOI] [PubMed] [Google Scholar]
  • 3.Sarubbi F.A. Hyperinfection with strongyloides during treatment of pemphigus vulgaris. Arch Dermatol. 1987;123:864–865. doi: 10.1001/archderm.1987.01660310028005. [DOI] [PubMed] [Google Scholar]
  • 4.Reddy I.S., Swarnalata G. Fatal disseminated Strongyloidiasis in patients on immunosuppressive therapy: Report of two cases. Indian J Dermato Venerol Leprol. 2005;71:38–40. doi: 10.4103/0378-6323.13785. [DOI] [PubMed] [Google Scholar]
  • 5.Marcos L.A., Terashima A., Dupont H.L., Gotuzzo E. Strongyloides hyperinfection syndrome: an emerging global infectious disease. Trans R Soc Trop Med Hyg. 2008;102:314–318. doi: 10.1016/j.trstmh.2008.01.020. [DOI] [PubMed] [Google Scholar]
  • 6.Nutman T.B., Keiser P.B. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev. 2004;17:208–217. doi: 10.1128/CMR.17.1.208-217.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Potter A., Stephens d., de Keulenaer B. Strongyloides hyperinfection: a case for awareness. Ann Trop Med Parasitol. 2003;97:855–860. doi: 10.1179/000349803225002453. [DOI] [PubMed] [Google Scholar]

References

  • 1.Chalumeau M., Clainche Le L., Sayeg N., Sannier N., Michel L.J., Marianowski R., et al. Spontaneous pneumomediastinum in children. Pediatr Pulmnol. 2001;31:67–75. doi: 10.1002/1099-0496(200101)31:1<67::AID-PPUL1009>3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]
  • 2.Hasegawa M., Hashimoto K., Moruzumi M., Ubukata K., Takahashi T., Inamo Y. Spontaneous pneumomediastinum complicating pneumonia in children infected with 2009 pandemic influenza A (H1N1) virus. Clin Microbiol Infect. 2010;16:195–199. doi: 10.1111/j.1469-0691.2009.03086.x. [DOI] [PubMed] [Google Scholar]
  • 3.Patric LC. Pneumomediastinum: treatment and medication. Available from http://emedicine medscape.com/article//1003409-treatment. Accessed on March 30, 2010.
  • 4.Tonelli R.A., Ruiz-Rodriguezs O., Jeminez J.E. Successful use of high-frequency oscillator ventilation for acute respiratory distress syndrome with pneumomediastinum. Respiratory Medicine CME. 2009;2:173–175. doi: 10.1016/j.rmedc.2009.01.011. [DOI] [Google Scholar]
  • 5.Caceres M., Ali Z.S., Braud R., Weiman D., Garrett E. Spontaneous pneumomediastinum: A comparative study and review of the literature. Ann Thorac Surg. 2008;86:962–966. doi: 10.1016/j.athoracsur.2008.04.067. [DOI] [PubMed] [Google Scholar]

References

  • 1.Gandhi N.R., Moll A., Sturm A.W., Pawins Ki R., Govender T., Lalloo U., et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006;368:1575–1580. doi: 10.1016/S0140-6736(06)69573-1. [DOI] [PubMed] [Google Scholar]
  • 2.Shah N.S., Wright A., Bai G.H., Barrera L., Boulah B., Martin-Casabona N., et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis. 2007;13:380–387. doi: 10.3201/eid1303.061400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.World Health Organization (WHO). Guidelines for the programmatic management of drug resistance tuberculosis. Emergency Update 2008. Geneva. Available at URL: http://whqlibdoc.who.int/publications/2008/9789241547581_eng.pdf. Accessed on 15th May, 2010.
  • 4.Shah N.S., Pratt R., Armstrong L., Robison V., Castro K.G., Cegielski J.P. Extensively drug-resistant tuberculosis in the United States, 1993–2007. JAMA. 2008;300:2153–2160. doi: 10.1001/jama.300.18.2153. [DOI] [PubMed] [Google Scholar]
  • 5.Kant L. Childhood tuberculosis: increasing but neglected. Indian J Tuberculosis. 2001;48:1. [Google Scholar]

Articles from Indian Pediatrics are provided here courtesy of Nature Publishing Group

RESOURCES